Functional genomic screens to identify new therapeutic targets for bowel cancer
Project description
Bowel/colon cancer is a major cause of cancer related morbidity worldwide. We will use novel genomic technologies (e.g. CRISPR-Cas12) to perform unbiased parallel combinatorial screen to identify synthetic lethality and druggable combinatorial approaches to inhibit colorectal cancer growth and progression.